Back to top
more

Neogen (NEOG)

(Real Time Quote from BATS)

$15.60 USD

15.60
289,276

0.00 (0.00%)

Updated Oct 2, 2024 12:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Neogen (NEOG) Hits New 52-Week High: What's Driving It?

by Zacks Equity Research

Strong performance in both its Animal Safety and Food Safety segments during the fiscal third quarter pushes Neogen (NEOG) to a 52-week high.

    NEOGEN's (NEOG) Earnings Miss Estimates in Q3, Margins Up

    by Zacks Equity Research

    NEOGEN's (NEOG) third-quarter fiscal 2021 revenues increase 16.9% year over year, driven by strong segmental growth and robust international business.

    Neogen (NEOG) Q3 Earnings Miss Estimates

    by Zacks Equity Research

    Neogen (NEOG) delivered earnings and revenue surprises of -7.41% and 9.00%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?

    Neogen (NEOG) Earnings Expected to Grow: What to Know Ahead of Q3 Release

    by Zacks Equity Research

    Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    NEOGEN's (NEOG) New Test to Identify Coronavirus in Wastewater

    by Zacks Equity Research

    Launch of NEOGEN's (NEOG) latest test, which marks its entry into wastewater testing, is expected to become a key tool to combat COVID-19.

    Neogen (NEOG) Up 5.1% Since Last Earnings Report: Can It Continue?

    by Zacks Equity Research

    Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    NEOGEN's (NEOG) New Test to Aid in Detecting Cancer-Causing Toxin

    by Zacks Equity Research

    NEOGEN's (NEOG) latest test is expected to simplify the process of milk testing as well as detecting lower levels of the carcinogenic metabolite Aflatoxin M1.

    Neogen (NEOG) Launches Dairy Toxin Detection Test Reveal Q+

    by Zacks Equity Research

    Neogen's (NEOG) new test can detect cancer causing aflatoxin M1 in milk within a range of 150-600 parts per trillion (ppt).

    New Strong Sell Stocks for January 12th

    by Zacks Equity Research

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

    NEOGEN (NEOG) Fortifies Global Position via Megazyme Buyout

    by Zacks Equity Research

    NEOGEN's (NEOG) buyout of Megazyme is expected to strengthen its Food Safety business worldwide.

    NEOGEN (NEOG) Q2 Earnings and Revenues Fall Shy of Estimates

    by Zacks Equity Research

    NEOGEN's (NEOG) segmental revenues improve for fiscal second quarter on strong sales of cleaners and disinfectants.

    Here's Why You Should Hold onto NEOGEN (NEOG) Stock for Now

    by Zacks Equity Research

    Investors continue to be optimistic about NEOGEN (NEOG) on robust segmental and geographical growth.

    Neogen (NEOG) Q2 Earnings and Revenues Lag Estimates

    by Zacks Equity Research

    Neogen (NEOG) delivered earnings and revenue surprises of -6.25% and -0.39%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

    NEOGEN (NEOG) Launches DNA Screening Tool for Canine Care

    by Zacks Equity Research

    NEOGEN's (NEOG) latest DNA screening tool is expected to aid veterinarians to provide healthy lifestyle recommendations for a longer and happier life for each pet and its family.

    NEOGEN (NEOG), Transnetyx Partner to Advance Mouse Genotyping

    by Zacks Equity Research

    NEOGEN (NEOG) aims to better serve the biomedical research community with a comprehensive and affordable solution for the genetic background testing of their mouse models via the partnership.

    Neogen (NEOG) Down 5.8% Since Last Earnings Report: Can It Rebound?

    by Zacks Equity Research

    Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?

    by Zacks Equity Research

    Sector ETF report for PSCH

    Here's Why You Should Add NEOGEN (NEOG) to Your Portfolio Now

    by Zacks Equity Research

    Investors continue to be optimistic about NEOGEN (NEOG) on robust segmental and geographical growth.

    Is Neogen (NEOG) a Solid Growth Stock? 3 Reasons to Think " Yes "

    by Zacks Equity Research

    Neogen (NEOG) possesses solid growth attributes, which could help it handily outperform the market.

    Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?

    by Zacks Equity Research

    Sector ETF report for PSCH

    NEOGEN (NEOG) Q1 Earnings and Revenues Surpass Estimates

    by Zacks Equity Research

    NEOGEN's (NEOG) segmental revenues improve for the fiscal first quarter on strong sales of cleaners, disinfectants and sanitizers.

    Company News for Sep 23, 2020

    by Zacks Equity Research

    Companies in the news are: NEOG, TSLA, BPMC, BLNK

    Neogen (NEOG) Surpasses Q1 Earnings and Revenue Estimates

    by Zacks Equity Research

    Neogen (NEOG) delivered earnings and revenue surprises of 11.11% and 5.07%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?

    Earnings Preview: Neogen (NEOG) Q1 Earnings Expected to Decline

    by Zacks Equity Research

    Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    OMRI Clears NEOGEN's AquaPrime Peraside 15 as USDA Compliant

    by Zacks Equity Research

    NEOGEN (NEOG) completes organic certified water treatment program with the latest certification.